CGL
DGX icon

Clarius Group LLC’s Quest Diagnostics DGX Stock Holding History

Clarius Group LLC’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-1,316
Closed -$236K – 414
2025
Q2 		$236K Sell
1,316
-105
-7% -$18.2K 0.01% 418
2025
Q1 		$240K Buy
1,421
+65
+5% +$10.7K 0.02% 410
2024
Q4 		$205K Buy
1,356
+3
+0.2% +$467 0.01% 423
2024
Q3 		$210K Buy
+1,353
New +$202K 0.01% 420
2024
Q2 		– Sell
-1,505
Closed -$200K – 465
2024
Q1 		$200K Buy
1,505
+50
+3% +$6.49K 0.01% 460
2023
Q4 		$201K Buy
+1,455
New +$191K 0.02% 457
2023
Q3 		– Sell
-1,812
Closed -$255K – 478
2023
Q2 		$255K Buy
1,812
+17
+0.9% +$2.34K 0.02% 439
2023
Q1 		$254K Sell
1,795
-68
-4% -$9.73K 0.02% 432
2022
Q4 		$291K Buy
1,863
+82
+5% +$11.8K 0.03% 391
2022
Q3 		$219K Buy
1,781
+143
+9% +$18.8K 0.02% 425
2022
Q2 		$218K Buy
1,638
+88
+6% +$12K 0.02% 421
2022
Q1 		$268K Hold
1,550
– – 0.02% 395
2021
Q4 		$268K Buy
+1,550
New +$236K 0.02% 395

Other funds holding DGX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Clarius Group LLC's DGX Position: Q3 2025 in Review

Clarius Group LLC sold out of Quest Diagnostics (DGX) in Q3 2025, closing a stake of 1,316 shares — an estimated $236K sold.

Clarius Group LLC first reported a position in DGX in Q4 2021 and held it in 13 quarters. The position peaked at $291K in Q4 2022. 1,006 funds tracked by Wall St. Rank hold DGX as of Q3 2025.

  • Clarius Group LLC reported no remaining Quest Diagnostics position as of Q3 2025 after selling out during the quarter.
  • Clarius Group LLC sold 1,316 Quest Diagnostics shares in Q3 2025, an estimated $236K.
  • Clarius Group LLC first reported a position in Quest Diagnostics in Q4 2021 and held it in 13 quarters.
  • Clarius Group LLC's Quest Diagnostics position peaked at $291K in Q4 2022.
  • 1,006 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2025.

Based on Clarius Group LLC's 13F filing for Q3 2025, filed 14 Oct 2025.